Maybridge plc of Cornwall, UK, has been acquired by Fisher Scientific International.
Maybridge plc of Cornwall, UK, has been acquired by Fisher Scientific International.
The acquisition was concluded at the end of November 2002.
Maybridge is a leading supplier of organic compounds and screening libraries for use in drug discovery. Fisher Scientific International, the world leader in serving science, provides products and services to customers in research, healthcare, educational and government markets worldwide.
The acquisition of Maybridge provides drug-discovery tools that will expand Fisher Scientific's product and service offering for its life-science customers.
Based in Tintagel, UK, Maybridge plc is a leading producer of organic compounds used in high-throughput screening (HTS) and combinatorial chemistry.
The Maybridge HTS collection consists of more than 53,000 organic drug-like compounds, produced by innovative synthetic techniques, often unique to Maybridge.
The CombiChem unit produces compounds for combinatorial chemistry applications in the lead optimisation process.
Maybridge also offers a unique range of reactive intermediates specifically designed for lead optimisation.
Fisher Scientific International (NYSE: FSH) is the world leader in serving science.
Fisher enables scientific discovery and clinical-laboratory testing services by offering more than 600,000 products and services to over 350,000 customers in approximately 145 countries.
As a result of its broad product offering, electronic-commerce capabilities, and integrated global logistics network, Fisher serves as a one-stop source of products, services and global solutions for many of its customers.
The company's primary target markets are scientific research and healthcare.
